1. Home
  2. AIRE vs ICCC Comparison

AIRE vs ICCC Comparison

Compare AIRE & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo reAlpha Tech Corp.

AIRE

reAlpha Tech Corp.

HOLD

Current Price

$0.46

Market Cap

56.9M

Sector

N/A

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$6.32

Market Cap

55.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIRE
ICCC
Founded
2021
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.9M
55.5M
IPO Year
N/A
1987

Fundamental Metrics

Financial Performance
Metric
AIRE
ICCC
Price
$0.46
$6.32
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$2.00
N/A
AVG Volume (30 Days)
6.1M
36.3K
Earning Date
11-12-2025
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
$4,149,567.00
$27,769,304.00
Revenue This Year
$456.19
N/A
Revenue Next Year
$105.16
N/A
P/E Ratio
N/A
$23.43
Revenue Growth
994.18
16.49
52 Week Low
$0.14
$4.28
52 Week High
$2.29
$7.60

Technical Indicators

Market Signals
Indicator
AIRE
ICCC
Relative Strength Index (RSI) 46.96 60.98
Support Level $0.40 $5.80
Resistance Level $0.60 $7.12
Average True Range (ATR) 0.04 0.34
MACD 0.00 0.02
Stochastic Oscillator 27.74 50.64

Price Performance

Historical Comparison
AIRE
ICCC

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: